UroGen Pharma Ltd. (URGN) Institutional Ownership

Ownership Summary

UroGen Pharma Ltd. (NASDAQ:URGN) currently has 159 active institutional owners and shareholders as of today (September 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• The percentage of UroGen Pharma owned by institutions changed from 85.8% in June 2025 to 97.8% in September 2025, marking a slight up trend.
• On a quarter-over-quarter basis, institutional holdings shifted by 21.28%, with a year-over-year an increase of 25.20% in the count of filers.
• The latest 13F cycle for UroGen Pharma reveals that of 159 total investors, 73 funds grew their exposure, whereas 55 reduced theirs and 31 made no changes.
• The aggregate institutional position in UroGen Pharma now stands at 45.24Mn shares as of September 2025, after investors increased their holdings (up by 7.94Mn shares quarter on quarter which is up 10.20Mn shares year over year).
• RTW INVESTMENTS, LP's holding of 4.54Mn shares as of September 30, 2025 makes it the primary institutional investor in UroGen Pharma, owning 9.82% of the stock.
• Among the most significant buyers of UroGen Pharma during September 2025 were Paradigm Biocapital Advisors LP (4.22Mn), Caption Management, LLC (1.02Mn), MILLENNIUM MANAGEMENT LLC (874.81K), D. E. Shaw & Co., Inc. (861.50K), TCG Crossover Management, LLC (717.35K).
• Leading sellers of UroGen Pharma stock in September 2025 included Soleus Capital Management, L.P. (1.51Mn), SILVERARC CAPITAL MANAGEMENT, LLC (445.20K), CITIGROUP INC (380.20K), Kynam Capital Management, LP (374.16K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (337.60K).
• The top 10 institutional holders of UroGen Pharma for the quarter ending September 2025 included RTW INVESTMENTS, LP (4.54Mn), Paradigm Biocapital Advisors LP (4.22Mn), TORONTO DOMINION BANK (3.19Mn), BlackRock, Inc. (2.58Mn), MORGAN STANLEY (2.53Mn), Jefferies Financial Group Inc. (2.20Mn), SILVERARC CAPITAL MANAGEMENT, LLC (1.58Mn), MILLENNIUM MANAGEMENT LLC (1.51Mn), ACORN CAPITAL ADVISORS, LLC (1.26Mn), SG Americas Securities, LLC (1.16Mn).